Atorvastatin Calcium/Losartan Potassium

阿托伐他汀钙/氯沙坦钾

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAtorvastatin Calcium/Losartan Potassium
Drug Alias Name阿托伐他汀钙+氯沙坦钾Atorvastatin Calcium•Losartan PotassiumAtorvastatin Calcium-Losartan Potassium阿托伐他汀钙/氯沙坦Atorvastatin Calcium and Losartan Potassium +[18] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsYes Losartan PotassiumAtorvastatin Calcium Hydrate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanall
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanAll Biopharma Co LtdYuhan Corp
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasEssential HypertensionHypertension

Other Information

ATC CodeN/A
Related LinksN/A